Baxter International Inc (MIL:1BAX)
€ 32.01 0 (0%) Market Cap: 14.28 Bil Enterprise Value: 25.64 Bil PE Ratio: 145.90 PB Ratio: 1.89 GF Score: 45/100

Baxter International Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 01:30PM GMT
Unidentified Analyst

Amazing. Thank you, everyone. You've got Patrick on the U.S. Medtech team. I'm obviously delighted today to have Jose Almeida, the CEO of Baxter; and Clare Trachtman, who runs the IR function to join us for what should be a fun chat. Before I get started, we've got the delightful disclosures, Morganfamily.com/researchdisclosures and then also you can reach out to your sales rep if any of you feel -- on and need to do so.

Questions & Answers

Unidentified Analyst

Thank you so much for joining us both and Joe, maybe if we could start with sort of a bigger picture question for Baxter. Innovation and driving growth up to that mid-single-digit range is kind of a key focus. How do you feel the pipeline of innovation is looking and what are you most excited about?

Jose E. Almeida
Baxter International Inc. - Chairman of the Board, President & CEO

I think we look at the growth story for Baxter in 3 different vectors. The first vector is acceleration of commercial execution. So going to areas of health

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot